Novel Drug May Offer Hope in Prader-Willi Syndrome, ObesityNovel Drug May Offer Hope in Prader-Willi Syndrome, Obesity

Beloranib reduces weight and hyperphagia in Prader-Willi syndrome and may also hold promise for other severe obesity conditions, but first the company must prove that it doesn't raise thrombotic risk. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news